Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B—A single center retrospective study of 466 patients

Abstract

The noninvasive measurement of liver stiffness (LS) was evaluated by transient elastography (FibroScan) and the possible influencing factors from the patients’ clinical situations including age, gender, liver inflammation represented by alanine transaminase (ALT) and total billirubin (TBIL) level, HBV replication (HBV DNA loads), portal vein pressure (portal vessel diameter, PVD), splenic thickness (SPT) and body mass index (BMI) were analyzed in patients with chronic hepatitis B (CHB). A total of 466 patients including 31 patients with acute-on-chronic liver failure (ACLF), and 435 patients with chronic hepatitis B (CHB) among which 82 patients were diagnosed with liver cirrhosis (LC) by clinical manifestations and liver B-type ultrasonic inspection were enrolled at Tongji Hospital from April to December 2009. LS was measured by a FibroScan device (EchoSens, France). Simultaneously, ALT and TBIL levels, HBV DNA loads, PVD, SPT and BMI in all patients were also tested. Forty-one healthy volunteers served as controls. The values of LS were correlated positively with ages of CHB patients and significantly higher in males than in females. In patients with BMI>28 kg/m² (obesity) and abnormal levels of ALT and TBIL, LS values were significantly increased as compared with those having normal levels of ALT and TBIL. The patients with ACLF had the highest LS value. Furthermore, LS values in the patients with LC were significantly higher than those in patients without LC. It is concluded that noninvasive measurement of liver fibrosis by FibroScan provides an alternative method to evaluate liver fibrosis of patients with CHB. In order to properly illustrate the stiffness value taken by transient elastography, patients’ gender should be taken into consideration and it is also suggested to avoid possible influencing factors including liver inflammation (high levels of ALT and TBIL) and obesity (high BMI).

Keywords

chronic hepatitis B / liver stiffness / FibroScan / liver fibrosis

References

[1] SandrinL., FourquetB., HasquenophJ.M., et al.. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol, 2003, 29(12): 1705-1713

[2] OgawaE., FurusyoN., ToyodaK., et al.. Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res, 2007, 37(12): 1002-1010

[3] Ganne-CarrieN., ZiolM., de LedinghenV., et al.. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology, 2006, 44(6): 1511-1517

[4] BoursierJ., KonateA., GoreaG., et al.. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol, 2008, 6(11): 1263-1269

[5] FraquelliM., RigamontiC., CasazzaG., et al.. Reprodu cibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut, 2007, 56(7): 968-973

[6] ZiolM., Handra-LucaA., KettanehA., et al.. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 2005, 41(1): 48-54

[7] GhanyM.G., DooE.. Assessment of liver fibrosis: palpate, poke or pulse?. Hepatology, 2005, 42(4): 759-761

[8] LucidarmeD., FoucherJ., Le BailB., et al.. Factors of accuracy of transient elastography (FibroScan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology, 2009, 49(4): 1083-1089

[9] SebastianiG., HalfonP., CasteraL., et al.. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology, 2009, 49(6): 1821-1827

[10] Nguyen-KhacE., ChatelainD., TramierB., et al.. Assessment of asymptomatic liver fibrosis in alcoholic patients using FibroScan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther, 2008, 28(10): 1188-1198

[11] SarinS.K., KumarA., AlmeidaJ.A., et al.. Acute-on-chronic liver failure: consensus recommendations of the Asian Paci? Association for the Study of the Liver (APASL). Hepatol Int, 2009, 3(1): 269-282

[12] ZhouB.. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2002, 23(1): 5-10

[13] CasteraL., FornsX., AlbertiA.. Non-invasive evaluation of liver fibrisis using transient elastography. J Hepatol, 2008, 48(5): 835-847

[14] PappasG., PapadimitriouP., FalagasM.E.. World wide web hepatitis B virus resources. J Clin Virol, 2007, 38(2): 161-164

[15] FriedmanS.L.. Mechanisms of hepatic fibrogenesis. Gastroenterology, 2008, 134(6): 1655-1669

[16] HadziyannisS.J., TassopoulosN.C., HeathcoteE.J., et al.. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology, 2006, 131(6): 1743-1751

[17] BrunoS., StroffoliniT., ColomboM., et al.. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology, 2007, 45(3): 579-587

[18] BenyonR.C., IredaleJ.P.. Is liver fibrosis reversible?. Gut, 2000, 46(4): 443-446

[19] VeldtB.J., HeathcoteE.J., WedemeyerH., et al.. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med, 2007, 147(10): 677-684

[20] CasteraL., VergniolJ., FoucherJ., et al.. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology, 2005, 128(2): 343-350

[21] CrossT.J., CalvarusoV., MaimoneS., et al.. Prospective comparison of FibroScan, King’s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat, 2010, 17(8): 546-554

[22] SeegerC., MasonW.S.. Hepatitis B virus biology. Microbiol Mol Biol Rev, 2000, 64(1): 51-68

[23] JungM.C., PapeG.R.. Immunology of hepatitis B infection. Lancet Infect Dis, 2002, 2(1): 43-50

[24] ZouY., ChenT., HanM., et al.. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol, 2010, 184(1): 466-475

[25] WuZ., HanM., ChenT., et al.. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int, 2010, 30(6): 782-794

[26] SirliR., SporeaI., TudoraA., et al.. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness?. J Gastrointestin Liver Dis, 2009, 18(1): 57-60

[27] RoulotD., CzernichowS., Le Clesiai]H., et al.. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol, 2008, 48(4): 606-613

[28] YasudaM., ShimizuI., ShibaM., et al.. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology, 1999, 29(3): 719-727

[29] FoucherJ., CasteraL., BernardP.H., et al.. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol, 2006, 18(4): 411-412

[30] CocoB., OliveriF., MainaA.M., et al.. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat, 2007, 14(5): 360-369

[31] OliveriF., CocoB., CiccorossiP., et al.. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol, 2008, 14(40): 6154-6162

[32] ArenaU., VizzuttiF., CortiG., et al.. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology, 2008, 47(2): 380-384

[33] MarsdenP.A., NingQ., FungL.S., et al.. The Fgl2/ fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest, 2003, 112(1): 58-66

[34] MarcellinP., ZiolM., BedossaP., et al.. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int, 2009, 29(2): 242-247

[35] BertolettiA., GehringA.J.. The immune response during hepatitis B virus infection. J Gen Virol, 2006, 87(Pt6): 1439-1449

[36] ChanH.L., WongG.L., ChoiP.C., et al.. Alanine aminotra-nsferase-based algorithms of liver stiffness measurement by transient elastography (FibroScan) for liver fibrosis in chronic hepatitis B. J Viral Hepat, 2009, 16(1): 36-44

[37] LiL.F., DaiL., ZhangQ., et al.. Factors influencing the success rate and stability of transient elastography for liver fibrosis evaluation. Nan Fang Yi Ke Da Xue Xue Bao (Chinese), 2008, 28(4): 595-597